Carter, R.J., Milani, M., Butterworth, M., Alotibi, A., Harper, N., Yedida, G., Greaves, G., Al-Zebeeby, A., Jorgensen, A.L., Schache, A.G., Risk, J.M., Shaw, R.J., Jones, T.M., Sacco, J.J., Hurlstone, A., Cohen, G.M., Varadarajan, S. (2019) Exploring the potential of BH3 mimetic therapy in squamous cell carcinoma of the head and neck. Cell Death & Disease. 10:912
|
Hagege, A., Saada-Bouzid, E., Ambrosetti, D., Rastoin, O., Boyer, J., He, X., Rousset, J., Montemagno, C., Doyen, J., Pedeutour, F., Parola, J., Bourget, I., Luciano, F., Bozec, A., Cao, Y., Pagès, G., Dufies, M. (2022) Targeting of c-MET and AXL by cabozantinib is a potential therapeutic strategy for patients with head and neck cell carcinoma. Cell reports. Medicine. 3:100659
|
